Product
WU-NK-101
2 clinical trials
3 indications
Indication
Acute Myeloid LeukemiaIndication
Colorectal Cancer MetastaticIndication
Squamous Cell Carcinoma of Head and NeckClinical trial
A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)Status: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab for Advanced and/or Metastatic Colorectal Cancer (CRC) and Advanced and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)Status: Not yet recruiting, Estimated PCD: 2025-02-28